(R)-3-Aminopiperidine-2,6-dione hydrochloride

Catalog No.: 
ACTEWJ724
CAS No.: 
1801140-47-5
Molecular Formula: 
C5H9ClN2O2
Molecular Weight: 
164.59
(R)-3-Aminopiperidine-2,6-dione hydrochloride structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g96%$106.00In stockIn stock
5g96%$378.00In stockIn stock
10g96%$585.00In stockIn stock
25g96%$1287.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(R)-3-Aminopiperidine-2,6-dione hydrochloride
IUPAC Name(R)-3-aminopiperidine-2,6-dione hydrochloride
MDL No.MFCD15474942
Molecular FormulaC5H9ClN2O2
Molecular Weight164.59
SMILESO=C([C@H](N)CC1)NC1=O.[H]Cl
InChI KeyYCPULGHBTPQLRH-AENDTGMFSA-N
Synonym(R)-3-AMINOPIPERIDINE-2,6-DIONE HCL;(R)-3-Amino-piperidine-2,6-dione hydrochloride;D-2-Aminoglutarimide (hydrochloride);(R) 3-Aminopiperidine-2,6-diketone hydrochloride
CAS No.1801140-47-5
PubChem CID74889962

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACTEWJ724 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACTEWJ724 route product structure diagram
    ACTEWJ7241801140-47-5In Stock
Inquiry

2. ACTEWJ724 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTEWJ724 route product structure diagram
    ACTEWJ7241801140-47-5In Stock
Inquiry

3. ACTEWJ724 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACTEWJ724 route product structure diagram
    ACTEWJ7241801140-47-5In Stock
Inquiry

Comments (0)